Search results for "Secondary hyperparathyroidism"

showing 10 items of 16 documents

Factors influencing serum 25-hydroxivitamin D levels and other bone metabolism parameters in healthy older women

2016

Objective: Older women have frequently low serum 25-hydroxivitamin D (25[OH]D) concentrations, high parathormone (PTH) levels and low bone mineral density (BMD) values. Endogenous synthesis, dietary habits, sunlight exposure and fat-mass-mediated storage may influence 25(OH)D levels and bone metabolism, but the relevance of these factors in the elderly has yet to be fully elucidated. We aimed to investigate the influence of dietary vitamin D intake and fat mass on serum 25(OH)D levels and bone metabolism in older women. Design: Cross-sectional. Setting: Community. Participants: 218 fit older women attending a biweekly mild fitness program. Measurements: Dietary habits was investigated throu…

0301 basic medicinemedicine.medical_specialtyBone densityMedicine (miscellaneous)030209 endocrinology & metabolism25-hydroxyvitamin D; bone metabolism; dietary vitamin D intake; elderly; fat mass; Medicine (miscellaneous); Nutrition and Dietetics; Geriatrics and Gerontologydietary vitamin D intakeelderlyNOBone remodeling03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicinemedicineVitamin D and neurologyFemoral neckBone mineralHyperparathyroidism030109 nutrition & dieteticsNutrition and Dieteticsbusiness.industryfat massmedicine.disease25-hydroxyvitamin Dmedicine.anatomical_structureEndocrinologychemistry25-hydroxyvitamin D dietary vitamin D intake fat mass bone metabolism elderlyCalcifediolSecondary hyperparathyroidismbone metabolismGeriatrics and GerontologybusinessThe journal of nutrition, health & aging
researchProduct

25-hydroxy vitamin D levels in healthy premenopausal women: Association with bone turnover markers and bone mineral density

2008

Abstract Background Vitamin D deficiency is very common in elderly people while there are very few reports on its incidence, determinants and metabolic consequences in young subjects. Results In 608 young healthy premenopausal women participating in the BONTURNO study, levels of 25-hydroxyvitamin D [25(OH)D] below 20 ng/ml were found in almost a third of the women. Its levels were inversely ( P 2 ) and directly with sunlight exposure during the summer time, and latitude: i.e. the higher the latitude over Italy, the higher the 25(OH)D level. In women on contraceptive pill the mean 25(OH)D level was significantly increased even when the data were adjusted for age, BMI and sun exposure. 25(OH)…

AdultAgingmedicine.medical_specialtyHistologyBone densityPhysiologyEndocrinology Diabetes and MetabolismBone and Bonesvitamin D deficiencyBody Mass IndexBone remodelingBone DensityInternal medicinemedicineVitamin D and neurologyHumansBone ResorptionVitamin DBone mineralHyperparathyroidismbusiness.industryMiddle Agedmedicine.diseasebone mineral density; bone turnover markers; premenopausal women; secondary hyperparathyroidism; vitamin dEndocrinologyPremenopauseSunlightFemaleSecondary hyperparathyroidismbusinessBody mass indexBiomarkersBone
researchProduct

Intraoperative Parathyroid Hormone Monitoring During Parathyroidectomy for Hyperparathyroidism in Waiting List and Kidney Transplant Patients

2006

This report describes the use of the intraoperative parathyroid hormone (ioPTH) assay during parathyroidectomy in waiting list and transplanted patients. ioPTH levels were determined in 40 patients on the waiting list for kidney transplantation with secondary hyperparathyroidism who underwent subtotal parathyroidectomy and 9 transplanted patients with tertiary hyperparathyroidism who underwent removal of hyperplasic glands. Rapid PTH levels decreased significantly at each time period; the percentage decrease in rapid PTH levels was 61.3% among patients with IPT II and 70.2% in patients with IPT III at 10 minutes and 86.5% in patients with IPT II and 91% in patients with IPT III at 15 minute…

AdultMaleParathyroidectomymedicine.medical_specialtyWaiting Listsmedicine.medical_treatmentParathyroid hormoneTertiary hyperparathyroidismKidney transplantSubtotal ParathyroidectomyParathyroid GlandsMonitoring IntraoperativePreoperative Careparasitic diseasesmedicineHumansPostoperative PeriodKidney transplantationParathyroidectomyTransplantationHyperparathyroidismbusiness.industryHyperparathyroidismMiddle Agedmedicine.diseaseKidney TransplantationSurgeryAdult Female Humans Hyperparathyroidism/classification Hyperparathyroidism/etiology Hyperparathyroidism/surgery* Kidney Failure Chronic/complications* Kidney Transplantation* Male Middle Aged Monitoring Intraoperative/methods* Parathyroid Glands/surgery Parathyroid Hormone/blood* Parathyroidectomy* Postoperative Period Preoperative Care Waiting ListsParathyroid HormoneKidney Failure ChronicFemaleSurgerySecondary hyperparathyroidismbusinessTransplantation Proceedings
researchProduct

Parathyroid hormone is inversely related to endothelin-1 in patients on haemodialysis

2008

SUMMARY: Aim: Parathyroid hormone secretion is mainly influenced by hypocalcaemia, hyperphosphataemia and vitamin D deficiency. However, previous in vitro and in vivo studies showed that endothelin-1 can influence parathyroid hormone secretion. This study was aimed at evaluating this relationship in vivo in uraemic patients. Methods: Parathyroid hormone and endothelin-1 plasma concentrations were measured in 67 haemodialysed patients. Patients with history of cardiovascular diseases and those with parathyroid adenoma were excluded. Results: Plasma levels of endothelin-1 were found to be inversely related to those of parathyroid hormone (P < 0.04) The multiple regression analysis, carried ou…

AdultMalemedicine.medical_specialtyParathyroid hormonevitamin D deficiencyEnd stage renal diseaseRenal DialysisInternal medicinemedicineHumansHypocalcaemiachronic kidney disease dialysis end-stage renal disease endothelin-1 parathyroid hormone.AgedParathyroid adenomaEndothelin-1business.industryGeneral MedicineMiddle Agedmedicine.diseaseEndothelin 1EndocrinologyParathyroid HormoneNephrologyKidney Failure ChronicRegression AnalysisParathyroid hormone secretionFemaleSecondary hyperparathyroidismbusinessNephrology
researchProduct

SP619The effect of etelcalcetide in hemodialysis patients with secondary hyperparathyroidism in daily clinical practice. A prospective multicenter st…

2019

EtelcalcetideTransplantationPediatricsmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentmedicine.diseaseClinical PracticeMulticenter studyNephrologymedicineSecondary hyperparathyroidismHemodialysisbusinessNephrology Dialysis Transplantation
researchProduct

Is secondary hyperparathyroidism-related myelofibrosis a negative prognostic factor for kidney transplant outcome?

2011

Secondary hyperparathyroidism (HP) presenting with hypocalcemia and subsequent increased parathormone (PTH), is mainly identified in patients with chronic renal failure, which has been associated with variable degrees of bone marrow fibrosis. For suitable patients with end-stage renal disease (ESRD), kidney transplantation is recognized as the therapy of choice, being superior to dialysis in terms of quality of life and long-term mortality risk; in this regard interesting data show that increased time on dialysis prior to kidney transplantation is associated with decreased graft and patient survival. In our opinion an important and until now underestimated determinant of graft survival is t…

Nephrologymedicine.medical_specialtymedicine.medical_treatmentUrologySettore BIO/13 - Biologia ApplicataInternal medicinemedicineHumansMyelofibrosisKidney transplantationDialysisSettore MED/14 - NefrologiaHyperparathyroidismbusiness.industryGeneral MedicinePrognosismedicine.diseaseKidney TransplantationSurgerySettore MED/18 - Chirurgia Generalemedicine.anatomical_structurePrimary MyelofibrosisKidney Failure ChronicSecondary hyperparathyroidism myelofibrosis kidney transplant chronic renal desease hemopoietic stem cells ischemia/reperfusion damegeHyperparathyroidism SecondarySecondary hyperparathyroidismBone marrowStem cellbusinessMedical Hypotheses
researchProduct

Comparison between Rapid Intraoperative and Central Laboratory Parathormone Dosage in 12 Kidney Transplant Candidates

2016

Abstract Background The rapid intraoperative parathormone (PTH) and at central laboratory PTH dosage gives similar results. The central laboratory provides results in longer times and higher costs. Intraoperative measurement can reduce time and costs during parathyroidectomy. Methods Twelve patients undergoing parathyroidectomy for hyperparathyroidism renal transplant candidates were included. Diagnosis was made by laboratory tests (serum calcium, PTH) and imaging techniques (ultrasonography and scintigraphy). All patients presented PTH levels of >400 pg/mL (the limit value to be maintained in list for kidney transplantation) and resistant to medical therapy. For each patient, 2 blood sampl…

ParathyroidectomyAdultMalemedicine.medical_specialtyWaiting Listsmedicine.medical_treatmentOperative TimeParathyroid hormoneScintigraphyKidney transplantCentral laboratory03 medical and health sciences0302 clinical medicineMonitoring IntraoperativemedicineHumansKidney transplantationParathyroidectomyHyperparathyroidismTransplantationmedicine.diagnostic_testbusiness.industryMiddle Agedmedicine.diseaseKidney TransplantationSurgery; TransplantationSurgerySettore MED/18 - Chirurgia GeneraleParathyroid Hormone030220 oncology & carcinogenesisAnesthesiaKidney Failure Chronic030211 gastroenterology & hepatologySecondary hyperparathyroidismFemaleHyperparathyroidism SecondarySurgerybusiness
researchProduct

Use of monitoring intraoperative parathyroid hormone during parathyroidectomy in patients on waiting list for renal transplantation.

2007

This report describes the use of intraoperative parathyroid hormone (ioPTH) assay during parathyroidectomy for patients with secondary hyperparathyroidism on the waiting list for renal transplantation. The levels of ioPTH were determined among waiting list patients undergoing subtotal parathyroidectomy and tertiary hyperparathyroidism patients undergoing procedures. The levels of ioPTH were significantly reduced at 10 minutes by 59.7,3% among with secondary hyperparathyroidism and 68.9% among tertiary hyperparathyroidism. A 15 minutes it was 85% in secondary hyperparathyroidism and 89.7% in tertiary hyperparathyroidism. A decrement of 50% in basal values at 10 minutes and 85% decrement or m…

ParathyroidectomyAdultMalemedicine.medical_specialtyendocrine system diseasesWaiting Listsmedicine.medical_treatmentParathyroid hormoneTertiary hyperparathyroidismSubtotal ParathyroidectomyMonitoring IntraoperativemedicineHumansKidney transplantationAgedParathyroidectomyTransplantationbusiness.industryMiddle Agedmedicine.diseaseKidney TransplantationSurgeryTransplantationSettore MED/18 - Chirurgia Generalemedicine.anatomical_structureParathyroid HormoneSurgerySecondary hyperparathyroidismParathyroid glandFemaleHyperparathyroidism SecondarybusinessParathyroidectomy hyperparathyroidismTransplantation proceedings
researchProduct

A complex case of fatal calciphylaxis in a female patient with hyperparathyroidism secondary to end stage renal disease of graft and coexistence of h…

2012

Background: Calciphylaxis is a potentially fatal complication of persistent secondary hyperparathyroidism; its cause is still not clear. Unfortunately there is no close relation in severity of clinical picture, serological and pathological alteration. For this reason the prognosis is difficult to establish. Administration of sodium thiosulphate may reduce the precipitation of calcium crystals and improve the general clinical conditions before surgical parathyroidectomy, which seems the only therapeutic approach able to reduce the mortality risk in these patients. Methods and Results: A 60 year old female patient suffering from End Renal Stage Disease, on haemodialysis from 2001 due to the o…

ParathyroidectomyGraft Rejectionmedicine.medical_specialtymedicine.medical_treatmentCalciphylaxiSettore MED/08 - Anatomia PatologicaGeneral Biochemistry Genetics and Molecular BiologyEnd stage renal diseaseFatal OutcomeSecondary hyperparathyroidism; Calciphylaxis; Kidney transplant; ParathyroidectomymedicineHumansKidney transplantDialysisParathyroidectomySettore MED/14 - NefrologiaCalciphylaxisHyperparathyroidismbusiness.industryCalciphylaxisMiddle Agedmedicine.diseaseKidney TransplantationSurgeryTransplantationSecondary hyperparathyroidismSettore MED/18 - Chirurgia GeneraleHemolytic-Uremic SyndromeKidney Failure ChronicSecondary hyperparathyroidismFemaleHyperparathyroidism SecondaryComplicationbusinessBiomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
researchProduct

Mandibular Brown Tumor as a Result of Secondary Hyperparathyroidism: A Case Report with 5 Years Follow-Up and Review of the Literature

2021

Background: Brown tumor is a rare skeletal manifestation of secondary hyperparathyroidism. Although diagnosis of the disease is increasingly seen in early stages due to improved screening techniques, some patients still present in a progressed disease stage. The treatment depends on tumor mass and varies from a conservative approach with supportive parathyroidectomy to extensive surgical resection with subsequent reconstruction. Case presentation: We report a case of extensive mandibular brown tumor in a patient with a history of systemic lupus erythematosus, chronic kidney disease, and secondary hyperparathyroidism. Following radical resection of the affected bone, reconstruction could be …

Parathyroidectomymedicine.medical_specialtyHealth Toxicology and Mutagenesismedicine.medical_treatment030232 urology & nephrologyCase Reportradical resectionDiseaseFree flap03 medical and health sciencesjaw0302 clinical medicinesecondary hyperparathyroidismmedicineStage (cooking)microvascular reconstructionbusiness.industryRPublic Health Environmental and Occupational Health030206 dentistrymedicine.diseasebrown tumorSurgeryBrown tumorMedicineSecondary hyperparathyroidismbusinessRadical resectionKidney diseaseInternational Journal of Environmental Research and Public Health
researchProduct